This inventor holds 9 USPTO granted patents and 1 EPO patent. Top assignees: Aventis Pasteur S.a., Sanofi Pasteur Sa. Active years: 2003-2015.
Company Filing History:
Years Active: 2003-2015
Title: Michel Chevalier: Innovator in Vaccine Development
Introduction
Michel Chevalier is a prominent inventor based in Beaurepaire, France. He has made significant contributions to the field of vaccine development, holding a total of nine patents. His work focuses on enhancing vaccine efficacy and stability, particularly in relation to viral infections.
Latest Patents
Among his latest patents is a stabilizing excipient for inactivated whole virus vaccines. This invention relates to a vaccine composition that includes an inactivated whole virus and a stabilizing excipient. Another notable patent involves flu virus hemagglutinin-specific monoclonal antibodies. This invention recognizes an antigenic structure present on both H1 and H3 subtypes of type A flu viruses, as well as on type B flu viruses, specifically those belonging to the B/Victoria and B/Yamagata groups.
Career Highlights
Michel Chevalier has worked with leading companies in the pharmaceutical industry, including Aventis Pasteur and Sanofi Pasteur. His experience in these organizations has allowed him to contribute to groundbreaking advancements in vaccine technology.
Collaborations
Some of his notable coworkers include Tino Krell and Catherine Moste. Their collaborative efforts have furthered research and development in the field of immunology.
Conclusion
Michel Chevalier's innovative work in vaccine development has made a lasting impact on public health. His contributions continue to shape the future of immunization strategies.